4421 - 4430 of 8137 Results
Title
Year
- Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial2020RESTRICTEDTitle: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 7Start Page: 591End Page: 600Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30136-8Citation Count: 104
-
OPENTitle: Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 3Start Page: 574End Page: 587Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25811Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25811Citation Count: 70
-
OPENTitle: Genetic variants and functional pathways associated with resilience to Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 8Start Page: 2561End Page: 2575Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awaa209Best OA location URL: https://academic.oup.com/brain/article-pdf/143/8/2561/37356057/awaa209.pdfCitation Count: 112
-
RESTRICTEDTitle: LRRK2 Phosphorylation, More Than an EpiphenomenonJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00527Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00527/pdfCitation Count: 41
-
RESTRICTEDTitle: The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 10Issue #: 6Start Page: 912End Page: 912Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom10060912Best OA location URL: https://www.mdpi.com/2218-273X/10/6/912/pdf?version=1593094633Citation Count: 21
-
OPENTitle: β-Glucocerebrosidase activity in GBA -linked Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000009989Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455354Citation Count: 36
-
OPENTitle: ATP10B and the risk for Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 140Issue #: 3Start Page: 401End Page: 402Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-020-02172-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540943Citation Count: 15
- Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning2020OPENTitle: Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learningJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 47Issue #: 13Start Page: 2998End Page: 3007Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00259-020-04897-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680289Citation Count: 36
-
RESTRICTEDTitle: Neural activity in functional movement disorders after inpatient rehabilitationJournal Name: Psychiatry Research: NeuroimagingPublisher: Elsevier BVVol: 303Issue #:Start Page: 111125End Page: 111125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pscychresns.2020.111125Citation Count: 21
- White Matter Hyperintensities in the Synucleinopathies: Orthostatic Hypotension, Supine Hypertension, or Both?2020OPENTitle: White Matter Hyperintensities in the Synucleinopathies: Orthostatic Hypotension, Supine Hypertension, or Both?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 595End Page: 598Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13000Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13000Citation Count: 7